Great Point Partners LLC Galapagos Nv Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$42.27 - $57.6 $2.27 Million - $3.09 Million
-53,589 Reduced 14.89%
306,411 $13.1 Million
Q1 2022

May 16, 2022
BUY
$51.32 - $68.5 $3.08 Million - $4.11 Million
60,000 Added 20.0%
360,000 $22.3 Million
Q4 2021

Feb 14, 2022
BUY
$47.03 - $57.12 $14.1 Million - $17.1 Million
300,000 New
300,000 $16.5 Million

Others Institutions Holding GLPG

# of Institutions
85
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email